Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer

被引：0
|
作者：
Taekyu Lim
Jeeyun Lee
Duk Joo Lee
Ha Yeon Lee
Boram Han
Kyung Kee Baek
Hee Kyung Ahn
Su Jin Lee
Se Hoon Park
Joon Oh Park
Young Suk Park
Ho Yeong Lim
Kyoung-Mee Kim
Won Ki Kang
机构：
[1] University School of Medicine,Division of Hematology
[2] Sungkyunkwan University School of Medicine,Oncology, Department of Medicine, Samsung Medical Center Sungkyunkwan
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 68卷
关键词：
Gastric cancer; Everolimus; Capecitabine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：255 / 262
页数：7
相关论文
共 50 条
  • [21] Phase II trial of RAD001 plus carboplatin in patients with triple-negative metastatic breast cancer.
    Singh, Jasmeet Chadha
    Stein, Stacy
    Volm, Matthew
    Smith, Julia Anne
    Novik, Yelena
    Speyer, James L.
    Meyers, Marlene
    Adams, Sylvia
    Omene, Coral Oghenerukevwe
    Muggia, Franco
    Schneider, Robert
    Formenti, Silvia
    Davis, Samantha
    Beardslee, Brian
    Tiersten, Amy
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [22] PHASE I TRIAL OF RAD001 (EVEROLIMUS) IN COMBINATION WITH RADIOTHERAPY IN NON-SMALL CELL LUNG CANCER
    Deutsch, E.
    Lepechoux, C.
    Pignon, J. P.
    Tao, Y. T.
    Rivera, S.
    Bourgier, B. C.
    Angokai, M.
    Bahleda, R.
    Slimane, K.
    Angevin, E.
    Besse, B. B.
    Soria, J. C.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 : 9 - 9
  • [23] A Phase I Pilot Study of the Oral mTOR Inhibitor RAD001 in Combination with Capecitabine for Metastatic Breast Cancer.
    Chen, C. S.
    Chen, M. M.
    Imaoka, R. T.
    Svahn, T.
    Guardino, A. E.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 860S - 860S
  • [24] Multicenter Phase II Study of Everolimus in Patients With Previously Treated Metastatic Gastric Cancer
    Doi, Toshihiko
    Muro, Kei
    Boku, Narikazu
    Yamada, Yasuhide
    Nishina, Tomohiro
    Takiuchi, Hiroya
    Komatsu, Yoshito
    Hamamoto, Yasuo
    Ohno, Nobutsugu
    Fujita, Yoshie
    Robson, Matthew
    Ohtsu, Atsushi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (11) : 1904 - 1910
  • [25] Prediction of response to RAD001 (everolimus) in patients with metastatic renal cell carcinoma
    Seidel, C.
    Fenner, M.
    Merseburger, A.
    Heuser, M.
    Ganser, A.
    Gruenwald, V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer
    Hong, YS
    Song, SY
    Lee, SI
    Chung, HC
    Choi, SH
    Noh, SH
    Park, JN
    Han, JY
    Kang, JH
    Lee, KS
    Cho, JY
    [J]. ANNALS OF ONCOLOGY, 2004, 15 (09) : 1344 - 1347
  • [27] Efficacy of RAD001 (everolimus) against advanced gastric cancer with peritoneal dissemination
    Fumiko Taguchi
    Yasuo Kodera
    Yasufumi Katanasaka
    Kazuyoshi Yanagihara
    Tomohide Tamura
    Fumiaki Koizumi
    [J]. Investigational New Drugs, 2011, 29 : 1198 - 1205
  • [28] Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors
    Soria, J. -C.
    Shepherd, F. A.
    Douillard, J. -Y.
    Wolf, J.
    Giaccone, G.
    Crino, L.
    Cappuzzo, F.
    Sharma, S.
    Gross, S. H.
    Dimitrijevic, S.
    Di Scala, L.
    Gardner, H.
    Nogova, L.
    Papadimitrakopoulou, V.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 (10) : 1674 - 1681
  • [29] Prediction of response to RAD001 (Everolimus) in patients with metastatic renal cell carcinoma
    Seidel, C.
    Fenner, M.
    Merseburger, A.
    Heuser, M.
    Ganser, A.
    Gruenwald, V.
    [J]. ONKOLOGIE, 2010, 33 : 105 - 105
  • [30] Efficacy of RAD001 (everolimus) against advanced gastric cancer with peritoneal dissemination
    Taguchi, Fumiko
    Kodera, Yasuo
    Katanasaka, Yasufumi
    Yanagihara, Kazuyoshi
    Tamura, Tomohide
    Koizumi, Fumiaki
    [J]. INVESTIGATIONAL NEW DRUGS, 2011, 29 (06) : 1198 - 1205
12345